The Board of Directors and CEO, Andy Gotshalk, are pleased to be in the position of growth which enables the company to move to the new facility. “This move supports our position of building our domestic and international markets and providing cutting-edge products. In addition, this building was designed to expand both Blackrock NeuroMed and Blackrock Microsystems’ resources and capabilities to meet our customer needs today and into the future.” says Andy Gotshalk, CEO.

About Blackrock NeuroMed
Blackrock NeuroMed is located in the University of Utah Research Park in Salt Lake City, Utah, USA. The Blackrock NeuroMed mission is to leverage the core data acquisition system technologies of Blackrock Microsystems to deliver to our worldwide customers a next-generation, sophisticated EEG and single cell recording system.

SALT LAKE CITY (March 15, 2013) – Blackrock NeuroMed will demonstrate its portfolio of revolutionary EEG / LTM technology during the annual American Academy of Neurology Meeting held in San Diego, CA  March 18-21.

“Central to our company’s mission is unraveling the mystery of what causes different neurological disorders,” said Andrew Gotshalk, CEO Blackrock NeuroMed. “We look forward to attending this year’s AAN Conference so our team can demonstrate the potential of this highly-advanced technology that we believe will revolutionize diagnosis and therapy of epilepsy.”

The Cervello EEG/LTM System is the first and only technology available that combines a full range of research and clinical capabilities.  The Cervello Systems are ideally suited for LTM in Epilepsy, Invasive and Stereo-EEG recording providing up to 256 channels, full HD video recording and high sampling amplifiers that are HFO-ready.  The Cervello ICU EEG Monitoring System has full EEG monitoring capabilities and a smaller footprint or wall-mount option, which makes it ideally suited for the ICU.

Tom Keener, VPof Sales, Damon Gee, Regional Sales Manager, Shanna Ryan, Sr. Product Manager and Ben Barker, IT and Network Specialist will be demonstrating the technology at the Blackrock NeuroMed Booth 1432, AAN Meeting at the San Diego Convention Center:

Monday, March 18           4:30pm – 6:30pm

Tuesday, March 19          12:00pm – 5:00pm

Wednesday, March 20     12:00pm – 5:00pm

Thursday, March 21         11:00am – 3:00pm

SALT LAKE CITY (March 1, 2013) – Blackrock NeuroMed will demonstrate its revolutionary EEG / LTM technology during the Western Society of END Technologists Annual Meeting held in San Francisco, March 8-10.

“Since only one of every three patients who suffer from epilepsy are successfully treated with medication, diagnosis is central to understanding what triggers seizures. The WSET Annual Meeting provides comprehensive education for diagnostic & research practitioners in EEG, Evoked Potentials, and Intraoperative Monitoring and allows our team access to the top clinicians and practitioners and enables us to demonstrate how our advanced and revolutionary technology can help them provide real answers for patient care” said Andrew Gotshalk, Blackrock NeuroMed CEO.

The Cervello Elite System is the first and only technology available that combines a full range of research capabilities with HD Video monitoring and clinical EEG recording. The Elite system is available with up to 256 channels and synchronizes all data immediately for both clinical and research applications and new software significantly improves how technicians set up and map channels to the correct electrodes.

Tom Keener, Director of Sales and Damon Gee, Regional Sales Manager will be demonstrating the technology at the Blackrock NeuroMed Booth, Marriott Airport Waterfront Hotel, March 8-10.

SALT LAKE CITY (November 27, 2012) – Blackrock NeuroMed will demonstrate its revolutionaryelectrophysiology technology to the nation’s top neuroscientists, neurologists, neurosurgeons,epileptologists and EEG technical specialists during the annual meeting of the American EpilepsySociety that takes place this year in San Diego December 1-3.

“Since only one of every three patients who suffer from epilepsy are successfully treated withmedication, diagnosis is central to understanding what triggers seizures,” said Andrew Gotshalk,Blackrock NeuroMed CEO. “The AES Convention provides our team direct access to the topmedical specialists, scientists and researchers and enables us to work together to discover howour advanced and revolutionary technology can help them provide real answers for patients.”

The Cervello Elite System is the first and only technology available that combines a full range ofelectrophysiology research capability with High-Definition Video EEG monitoring. The system isavailable with up to 256 channels and synchronizes all data immediately for both clinical andresearch applications and new software significantly improves how technicians set up and mapchannels to the correct electrodes.

Standard EEG technology measures the energy of tens of thousands of neurons in the brain atonce. Blackrock NeuroMed’s CervelloTM Elite System measures and records signals from everytiny neuron, allowing the clinician unprecedented precision in identifying underlying causes ofwhat may be triggering disruption in the brain’s natural circuitry.

The Blackrock NeuroMed team will also demonstrate the Cervello ICU EEG Monitoring System,which has full EEG monitoring capabilities and a smaller footprint or wall-mount option ideallysuited for the ICU.

Tom Keener, Director of Sales, will lead the Blackrock NeuroMed Team, which includes ShannaRyan, Sr. Product Manager, Troy Pridgeon, Damon Gee, Mike Haydon, all Regional SalesManagers and Jake Smith, Technical Support.

Blackrock NeuroMed – San Diego Convention Center – Booth 419

Saturday December 1: 11:45 a.m. – 6:00 p.m.
Sunday, December 2: 11:00 a.m. – 6:00 p.m.
Monday, December 3: 11:00 a.m. – 3:00 p.m.

“Troy brings a rich combination of technical knowledge and sales experience to our company,” said Gotshalk. “He understands precisely how this new technology can meet and exceed the demands of neurologists and researchers and ultimately improve patient diagnosis and care.”

“Blackrock NeuroMed is a dynamic company with a team that is committed to quality and building partnerships with customers,” said Pridgeon. “I look forward to being a part of its growth and success.”

Troy Pridgeon graduated from Angelo State University with a BS in psychology. Early in his career, he held leadership positions in sleep disorder clinics at the University of Missouri and Olathe Medical Center. For the last nine years, Pridgeon has led sales teams at Embla Systems and Nihon Kohden America.

About Blackrock NeuroMed, LLC
Blackrock NeuroMed, is a spin-off of Blackrock Microsystems, and was founded in 2011 to deliver a sophisticated EEG and single cell recording system to clinicians worldwide. The company has a full portfolio of EEG recording devices to meet all of the EEG needs of a hospital or private practice.

“Damon’s international experience combined with his sophisticated knowledge of all aspects of neurotechnology make him a perfect fit for growing our company,” said Gotshalk. “He has a deep understanding of what it takes to meet the needs of leading medical and research professionals and we’re happy to have him on board.”

“I have a commitment to serving as the ‘voice of the customer,” said Gee. “I am excited to join the Blackrock NeuroMed team because they have created a system that is a significant step forward in neurotechnology.”

Damon Gee has a BA in psychology and business and an MS in cognition and neuroscience from the University of Texas at Dallas. Previously, Gee was Senior Sales Engineer and Product Manager for Plexon, Inc. in Dallas, Texas.

About Blackrock NeuroMed, LLC
Blackrock NeuroMed, is a spin-off of Blackrock Microsystems, and was founded in 2011 to deliver a sophisticated EEG and single cell recording system to clinicians worldwide. The company has a full portfolio of EEG recording devices to meet all of the EEG needs of a hospital or private practice.

Contact:
Maggie Montague
801-290-8019

The Cervello Elite system is the first and only technology available that combines a full range of electrophysiology research capability with a High Definition Video EEG recording system. It requires four cables, instead of the standard 128 individual connections, and synchronizes all data immediately for both clinical and research applications.

“Central to our mission is unraveling the mystery of what causes different neurological disorders,” said Andrew Gotshalk, CEO Blackrock NeuroMed. “We look forward to attending this year’s ASET Conference so that our team can demonstrate the promise and potential of this highly advanced technology that we believe will revolutionize diagnosis and therapy.”

Standard EEG technology measures the energy of tens of thousands of neurons in the brain at once. Blackrock NeuroMed’s Cervello Elite measures and records signals from each tiny neuron, allowing the clinician unprecedented precision in identifying underlying causes of what may be triggering disruption in the brain’s natural circuitry.

Tom Keener, Director of Sales will lead the team from Blackrock NeuroMed, which includes Shanna Ryan, Senior Product Manager and Troy Pridgeon, Regional Sales Manager. The team will demonstrate new software that significantly improves how technicians set up and map channels to the correct electrodes.

Visitors can also see a video featuring Dr. Jean Gotman, of the Montreal Neurological Institute, and McGill University. Dr. Gotman is a member of Blackrock NeuroMed’s scientific advisory board. He will discuss advances in EEG technology, including the Cervello Elite system.

Blackrock NeuroMed – Exhibitor Hall – Booth 26
Thursday, August 2
9:30 a.m. – 4:00 p.m.
6:00 p.m. – 7:30 p.m.

Friday, August 3
9:00 a.m. – Noon

The Neurotech Leaders Forum is ‘the’ management and investment conference for neurotech professionals. The two-day conference offers an exclusive forum for neurotechnoloy executives and entrepreneurs to interact with investors, technologists and potential partners who are actively working to grow this new and exciting industry.

Gotshalk is CEO of BlackRock NeuroMed. He has more than fifteen years of experience in commercializing medical devices. Most recently Andrew successfully commercialized research products in the neurophysiology sector (Blackrock Microsystems) increasing revenue from $700k to +$11 million in less than four years. Prior to that Andrew was responsible for sales and operations for the Surgical Division of Haemonetics Corporation. Andrew has a Bachelor of Science in Mechanical Engineering from the Georgia Institute of Technology.

Gotshalk will be speaking during the Consumer session on Tuesday, October 18. He will look at new technologies impacting the neurosensing industry, including new sensors, software, and imaging systems. He will also examine how current EEG products are limited by the amount of data provided. He will describe his option for higher resolution data and additional data streams that cover the need for improved levels of diagnosis and treatment capabilities for neurological disorders.

Neurotech Leaders Forum founder, James Cavuoto, enthusiastically recommends attending the session. “Andy’s company is changing the way research gets done. Their technology will enable products to get researched sufficiently and safely so they can get to market and help people who need them most.”

About Neurotech Leaders Forum
Debuted in 2001, Neurotech Leaders Forum covers a range of technologies and market segments in the neuro space, including neuromodulation, neural prosthetics, neurosensing, and neurorehabilitation. The 2011 keynote will be will delivered by Kip Ludwig, director for plasticity and repair at the NIH/NINDS. This year features a first-ever Consumer Neurotech Conference on October 18. The full-day meeting will include sessions on neuromarketing, gaming, training, and cognitive enhancement applications of neurotechnology. For more information on the 2011 Neurotech Leaders Forum, call: 415 546 1259.

About Blackrock NeuroMed
Launched in 2011, Blackrock NeuroMed delivers a sophisticated EEG and single cell recording system to clinicians worldwide. Their turn-key solutions facilitate the study and utilization of electrical signals acquired from the brain and peripheral nervous system. The company was founded by Professor Florian Solzbacher, Director of Utah Nanofabrication Laboratory and co-Director of the Utah Nanotechnology Institute. The company provides enabling tools for the neuroscience, neural engineering and neuroprosthetics research and clinical community worldwide.

“I am excited about Blackrock NeuroMed’s market position to fill a product gap in advanced clinical neuro-diagnostics and clinical research,” says Gotman. “The NeuroMed technology opens a new frontier in neuro-diagnostics and the Blackrock team brings strong product engineering and commercialization leadership to this industry.”

“We are very pleased to have Dr. Gotman as a part of our team,” says Andy Gotshalk, Blackrock Microsystems CEO. “He brings years of experience as a researcher and a successful businessman and is highly regarded in the field of clinical neuroscience.”

About Blackrock Microsystems LLC
Blackrock Microsystems provides enabling tools for neuroscience, neural engineering and neuroprosthetics research worldwide. The company is a leading provider of intelligent Microsystems that aid neuroscience researchers and physicians in the development of improved medical solutions.

Press Contact:
Jeff Chance
Blackrock Microsystems
391 Chipeta Way, Suite G
Salt Lake City, UT 84108
O 801.582.5533 x 248
jchance(at)blackrockmicro(dot)com
http://www.blackrockmicro.com ]]> http://blackrockneuromed.com/2011/03/blackrock-microsystems-launches-blackrock-neuromed-and-appoints-dr-jean-gotman-to-scientific-advisory-board/feed/ 0